Safety and effectiveness established in pediatric patients 6 months of age or older with community-acquired pneumonia. Use is supported by evidence from studies in adults with additional safety and PK data in pediatric patients Safety and effectiveness in the treatment of pediatric patients < 6 months of age have not been established. Safety and effectiveness in the treatment of pediatric patients with acute bacterial sinusitis have not been established Information on dose, PK parameters, AE profile, lab abnormalities, and clinical studies New indication
|